Private Advisor Group, LLC Seagen Inc. Transaction History

Private Advisor Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 14, 2022	SELL	$135.27 - $180.11 $6.32 Million - $8.42 Million	-46,740 Reduced 89.03%	5,762 $788,000
Q2 2022 Jul 13, 2022	BUY	$108.81 - $179.33 $4.46 Million - $7.35 Million	40,991 Added 356.1%	52,502 $9.29 Million
Q1 2022 May 12, 2022	SELL	$119.61 - $157.85 $7,894 - $10,418	-66 Reduced 0.57%	11,511 $1.66 Million
Q4 2021 Feb 10, 2022	SELL	$142.57 - $190.86 $593,233 - $794,168	-4,161 Reduced 26.44%	11,577 $1.79 Million
Q3 2021 Oct 14, 2021	BUY	$142.45 - $169.82 $730,626 - $871,006	5,129 Added 48.35%	15,738 $2.67 Million
Q2 2021 Aug 12, 2021	BUY	$135.08 - $161.1 $767,659 - $915,531	5,683 Added 115.37%	10,609 $1.68 Million
Q1 2021 Apr 22, 2021	SELL	$137.51 - $190.8 $248,480 - $344,775	-1,807 Reduced 26.84%	4,926 $684,000
Q4 2020 Apr 01, 2021	BUY	$164.63 - $211.93 $1.11 Million - $1.43 Million	6,733 New	6,733 $1.18 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.